MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ijlh.70216

Медицинская библиотека · International journal of laboratory hematology · 2026

Laboratory Concordance and Prognostic Impact of 10-Color Flow Cytometry and Next-Generation Sequencing-Based Immunoglobulin Gene Assay for Measurable Residual Disease Monitoring in Adult B-Cell Acute Lymphoblastic Leukemia: A Multicenter Study From Thai Acute Leukemia Working Group (TALWG).

Chanswangphuwana Chantiya, Limvorapitak Wasithep, Kobbuaklee Sirorat, Kansuwan Patsita, Wudhikarn Kitsada, Rojnuckarin Ponlapat, Owattanapanich Weerapat, Rattanathammethee Thanawat, Tantiworawit Adisak, Silpsamrit Panachai, Prayongratana Kannadit, Piyajaroenkij Thanakrit, Jit-Ueakul Dusit, Polprasert Chantana

СтатьяПеревод в очереди

Аннотация

AIMS: Measurable residual disease (MRD) is a key prognostic marker for patient survival. This study evaluated concordance between 10-color flow cytometry and next-generation sequencing (NGS)-based immunoglobulin heavy chain (IGH) gene assays for MRD detection and to assess prognostic significance in adult B-cell acute lymphoblastic leukemia (B-ALL).

METHODS

This multicenter prospective study enrolled 51 patients with newly diagnosed B-ALL. Bone marrow samples were obtained at diagnosis, post-induction (1 month), and post-early consolidation (3 months). Flow cytometry and NGS-IGH were performed at three timepoints to assess MRD B-ALL.

RESULTS

Patients were classified as high risk according to white blood cell count and cytogenetic features in 37.3% and 64.7% of patients, respectively. Treatment protocols included pediatric-inspired regimens (41.2%), adult-ALL protocols (52.9%), and low-intensity chemotherapy. All 16 Philadelphia chromosome-positive patients received tyrosine kinase inhibitors. Twenty patients underwent allogeneic hematopoietic cell transplantation (HCT) in first complete remission (CR). Median relapse-free survival (RFS) and overall survival were 19 and 39 months, respectively. MRD negativity at 3 months by either method correlated with significantly superior RFS. Allogeneic HCT also conferred RFS benefit. MRD positive patients without HCT had the worst RFS. Flow cytometry MRD positivity at 3 months independently predicted inferior RFS (HR 3.81; 95% CI 1.01-14.43). The overall concordance between flow cytometry and NGS was 80.7%.

CONCLUSION

MRD positivity at 3 months post-treatment strongly predicted relapse, supporting its use to guide therapeutic modifications of B-ALL. Apart from NGS-based IGH clonality assays, 10-color flow cytometry offers an alternative in resource-limited settings.

Для цитирования: Chanswangphuwana Chantiya, Limvorapitak Wasithep, Kobbuaklee Sirorat, Kansuwan Patsita, Wudhikarn Kitsada, Rojnuckarin Ponlapat, Owattanapanich Weerapat, Rattanathammethee Thanawat, Tantiworawit Adisak, Silpsamrit Panachai, Prayongratana Kannadit, Piyajaroenkij Thanakrit, Jit-Ueakul Dusit, Polprasert Chantana. Laboratory Concordance and Prognostic Impact of 10-Color Flow Cytometry and Next-Generation Sequencing-Based Immunoglobulin Gene Assay for Measurable Residual Disease Monitoring in Adult B-Cell Acute Lymphoblastic Leukemia: A Multicenter Study From Thai Acute Leukemia Working Group (TALWG).. International journal of laboratory hematology. 2026. DOI: 10.1111/ijlh.70216.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.